← Back to results

ChemMedChem · 2022

Nanoparticles-Mediated CRISPR/Cas Gene Editing Delivery System.

ChemMedChem, 17(9): e202100777 PMID 35261159 DOI 10.1002/cmdc.202100777

Open in PubMed ↗ Open via DOI ↗

Abstract

CRISPR/Cas system has become one of the most powerful techologies in biomedical research, and has showed great potentials in the gene related diseases. However, efficient delivery systems of CRISPR/Cas to target cells remains challenging. In recent years, nanoparticles have showned great potentials for the delivery of CRISPR/Cas systems. This paper mainly approaches the development and new strategies of CRISPR/Cas delivery systems, as well as their application in the clinical diseases. By summarizing the CRISPR/Cas systems delivery, new strategies are expected for the gene therapy.

Cite